entity

TREM2 signaling

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TREM2 signaling: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections

4Hypotheses

3Analyses

3Outgoing

4Incoming

0Experiments

4Debates

No AI portrait yet

Outgoing (3)

Target	Relation	Type	Str
Neurodegeneration-Associated Molecular Patterns Detection	mediates	process	0.90
Neuroinflammation	contributes_to	process	0.82
Neuroprotection	modulates	process	0.78

Incoming (4)

Source	Relation	Type	Str
31649511	is a ligand for and triggers	paper	0.90
Trem2 Variants	modulates	biomarker	0.90
41909127	suppresses	paper	0.90
APOE4	inhibits	gene	0.70

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign	0.827	neuroscience	Circuit-level neural dynamics in neurode
Astrocytic-Mediated Tau Clearance Dysfunction via TREM2 Sign	0.672	neuroscience	Circuit-level neural dynamics in neurode
Age-Dependent TREM2 Signaling Disrupts Astrocyte-Microglia C	0.649	neurodegeneration	Gene expression changes in aging mouse b
TREM2 Signaling Bifurcation with Independent TYROBP-Independ	0.586	neuroinflammation	Why is TYROBP deficiency neuroprotective

Mentioning Analyses (3)

Scientific analyses that reference this entity

What is the temporal sequence of TREM2 signaling transition from protective to i

neuroimmunology | 2026-04-15 | 1 hypotheses Top: 0.670

What are the optimal timing windows for TREM2 agonism vs antagonism across disea

neurodegeneration | 2026-04-11 | 0 hypotheses

APOE4 targeting in neurodegeneration

neurodegeneration | 2026-04-02 | 4 hypotheses Top: 0.720

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Targeting Microglial Phagocytosis for Alzheimer's Disease Management: Natural, P [PMID:40641018]	Raghuvanshi S, Mazumder A, Das S	CNS & neurological disorders d	2026
The APOE-Microglia Axis in Alzheimer's Disease: Functional Divergence and Therap [PMID:40722268]	Unknown	Brain sciences	2025
Soluble CSF1R promotes microglial activation and amyloid clearance in alzheimer' [PMID:41152873]	Zhang L, Chen K, Zeng R	J Neuroinflammation	2025
Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfuncti [PMID:36683512]	Basha SC, Ramaiah MJ, Kosagisharaf JR	J Alzheimers Dis	2023
LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurode [PMID:31257024]	["Heckmann Bradlee L", "Teubner Brett J	Cell	2019

Debates (4)

Multi-agent debates referencing this entity

Debate: TREM2 R47H Metabolic Lock-in at Cholesterol Ester Accumulation

closed · Rounds: 4 · Score: 0.59 · 2026-04-27

What are effective therapeutic strategies for targeting APOE4 in Alzheimer's dis

closed · Rounds: 4 · Score: 0.82 · 2026-04-22

The debate highlighted that TREM2 therapeutic targeting remains contested across

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

While TREM2 was identified as critical for microglial senescence, the debate lac

closed · Rounds: 4 · Score: 0.73 · 2026-04-15

Related Research

Hypotheses and analyses mentioning TREM2 signaling in their description or question text

No additional research found